| Methods
for Testing Vectors for
Replication Competent Virus (RCV) Most viral vectors used today are disabled such that replication competent viruses are not readily formed by any biological process that might occur in normal hosts. Biosafety encourages the use of such vectors in all relevant applications. In particularly sensitive applications, demonstrating that the viral stock used has no apparent contamination with replication competent vectors is essential for biosafety. Of course, assays for replication competence will never be perfect or absolute, so the Institutional Biosafety Committee (IBC) asks that one use a current procedure of demonstrated sensitivity and specificity. Below is a summary guide of the current IBC recommendations for common classes of vectors. If another procedure or reference method is used to accomplish the same conclusion, researchers are asked to submit that procedure and published article with their IBC registration. In general, the IBC will require use of such an assay whenever viruses or virus-infected cells are used in whole animals. Even more rigorous testing may be required in some instances, such as a vector bearing a pathogenic gene or in human gene therapy, or in any materials that could be released in the environment. Viral testing is not generally required if experiments are conducted entirely in tissue culture.
|
|||||||||||||||||||||
| 1 Please contact the Department of Biological Safety for an electronic copy of this article. | |||||||||||||||||||||
| Last
Updated 06.26.2007 Send Comments to D. Caskey |